01513.HK
Livzon Pharmaceutical Group, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 23.18
+4.32%Margins
Gross margin
61.0%
EBITDA margin
26.1%
EBIT margin
20.5%
Net margin
15.3%
FCF margin
27.4%
11.9%
Return on equity
6.7%
Return on assets
12.1%
Return on invested capital
0.43x
Asset turnover
HKD 3.8B
Cash from operations
HKD 9.71
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026